Actinium Pharmaceuticals to Present at Investment Conference

NEW YORK, Sept. 4, 2026 -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) has announced that its Chairman and Chief Executive Officer, Sandesh Seth, will be presenting at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation is scheduled to take place in September.

Actinium Pharmaceuticals focuses on the development of targeted radiotherapies for cancer treatment. The company aims to improve patient outcomes and reduce side effects through its therapeutic approaches.

The conference brings together companies and investors to discuss industry developments. Actinium's participation provides an opportunity to highlight its research and development efforts and discuss its business outlook with the financial community.